Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : TAK crawled time : 21:00 save search
Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Published: 2023-12-15 (Crawled : 21:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.21%
C: -1.79%
hyqvia chmp positive therapy
Arrowhead Pharmaceuticals Reports Fiscal 2023 Third Quarter Results
Published: 2023-08-07 (Crawled : 21:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.62%
H: 0.62%
C: 0.42%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.35%
H: 0.41%
C: 0.41%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: 0.0%
H: 0.44%
C: -2.65%
pharmaceuticals results
Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Published: 2023-02-23 (Crawled : 21:00) - globenewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -2.47%
H: 0.0%
C: -0.32%
CDXS | $2.815 0.54% 0.53% 470K
|
Process Industries
|
| O: -1.82%
H: 0.0%
C: -12.24%
year financial results
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
Published: 2023-01-27 (Crawled : 21:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.37%
H: 0.16%
C: -0.06%
california program funding
Global Bleeding Disorders Treatment Market Report 2022: Industry Trends, Share, Size, Growth, Opportunities and Forecasts 2021-2027
Published: 2023-01-19 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.08%
H: 0.0%
C: 0.0%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.19%
H: 0.8%
C: 0.62%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.23%
H: 0.56%
C: 0.55%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.34%
H: 0.01%
C: -0.8%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.41%
H: 0.0%
C: 0.0%
treatment bleeding global report market
Insights on the Narcolepsy Therapeutics Global Market to 2028 - Featuring Jazz Pharmaceuticals, Pfizer, Bioprojet and Takeda Pharmaceutical Among Others
Published: 2022-11-21 (Crawled : 21:00) - prnewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.71%
H: 0.85%
C: 0.42%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.53%
JAZZ | $109.96 0.63% 0.63% 760K
|
Health Technology
|
| O: 0.28%
H: 2.75%
C: 2.63%
global narcolepsy therapeutics market
Finch Therapeutics Regains Full Rights to FIN-524 and FIN-525 Targeted Microbiome Product Candidates in Development for IBD
Published: 2022-08-25 (Crawled : 21:00) - globenewswire.com
FNCH | $2.205 -6.57% -7.03% 30K
|
Professional, Scientific, and T...
|
| O: -8.01%
H: 4.86%
C: 2.43%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.78%
H: 0.65%
C: -1.44%
fin-524 therapeutics
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
Published: 2022-05-09 (Crawled : 21:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.69%
H: 0.28%
C: -1.1%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: 0.0%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: -2.88%
H: 2.34%
C: -8.64%
therapeutics
Insights on the Liver Disease Treatment Global Market to 2027 - by Treatment Type, Disease Type, End-user and Region
Published: 2022-04-12 (Crawled : 21:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: -4.71%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -0.83%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: 2.3%
H: 0.55%
C: 0.36%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.37%
H: 2.99%
C: 2.61%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.2%
H: 1.83%
C: 1.83%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.12%
H: 0.44%
C: 0.17%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.26%
H: 0.33%
C: -1.5%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.24%
H: 0.53%
C: 0.18%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: -3.67%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.7%
H: 1.91%
C: 1.63%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
treatment liver disease market
Worldwide Active Pharmaceutical Ingredient Industry to 2030 - Growing Importance of Generics is Driving the Market
Published: 2021-11-12 (Crawled : 21:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
| Email alert
Add to watchlist
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
growing
Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results
Published: 2021-05-04 (Crawled : 21:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: -1.25%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: -3.13%
H: 2.97%
C: -2.29%
results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.